The fast-selling GLP-1 drug matched Lilly's older medicine Trulicity in a closely watched cardiovascular outcomes trial, while showing greater weight loss and blood sugar control.

In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.

Asian shares are lower after choppy trading on Wall Street that saw more losses as investors assess President Donald Trump's ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund declined 5.06% ...

In an en banc petition filed this month before the U.S. Court of Appeals for the Ninth Circuit, Takeda Pharmaceutical and Eli Lilly sought rehearing of a June 16 decision upholding certification of a ...

Latham leaders said they had their eyes on recruiting David Marriott for “several years,” particularly after working ...

The biopharmaceutical industry is growing rapidly as a result of significant advancements in biotechnology and drug ...

New research results reported at the Alzheimer's Association International Conference® 2025 (AAIC®) advanced scientific understanding of ...

AI-led drug for chronic lung disease set to enter phase 3 clinical trials, though experts remain divided on AI's impact in ...